Beginner Fat Loss Protocol

The Beginner Fat Loss Protocol is designed for users new to GLP-1 receptor agonists who want to start with semaglutide — the most proven and well-established GLP-1 peptide, equivalent in mechanism to FDA-approved Ozempic and Wegovy. Semaglutide is the ideal starting point for GLP-1 protocols because its half-life, tolerability profile, and clinical evidence base are the most well-established. The 5mg vial provides approximately 20 weeks of dosing at the starting 0.25mg/week dose, giving new users ample time to find their effective dose without purchasing more peptide than needed before confirming personal tolerance. The titration approach is critical for GLP-1 beginners. Starting low and escalating slowly is not optional — it is the primary harm reduction strategy that determines whether the protocol is enjoyable or plagued by nausea. The slow titration schedule mirrors the clinical approach used in the STEP trials and significantly reduces side effect severity. Most beginners experience meaningful appetite reduction within 2–4 weeks at 0.5mg/week, making this dose the common "staying point" for users who achieve adequate fat loss without escalating further.